发明人沈红梅,徐明华,钱学锋. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 108536615 A, 授权公告日 2021-03-24.
发明人韩伟,沈红梅,冯建国. "Method for the Synthesis of Ethyl 5-(2-chlorophenyl)-2-(2-methoxybenzylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-carboxylate" [P]. 中国发明专利, 专利号 CN 113939626 B, 授权公告日 2017-07-19.
发明人罗永刚,徐明华,何建平. "A Process for Preparing High-Purity Ethyl 5-(2-chlorophenyl)-2-(2-methoxybenzylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-carboxylate" [P]. 中国发明专利, 专利号 CN 108949678 A, 授权公告日 2018-08-06.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2016, 111, 9936-9953.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2022, 2021, 4165-4169.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 5-(2-chlorophenyl)-2-(2-methoxybenzylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-carboxylate Using HRMS and NMR". J. Agric. Food Chem., 2010, 1674, (5), 6929-6943.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2014, 2324, 2190-2196.